Analysis of websites containing azpicentral.com backlinks
These websites are/were linking to azpicentral.com.
Websites found: 32
Number of websited displayed: 32
List of results:
BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) Inhalation Aerosolhttp://site-overview.com/stats/bevespiaerosphere.com
BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) is a long‐term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.
- Website Address renewal date: 17/8/9
- Domain Address Reg. date: 15/8/13
- Website address in use until: 18/8/13
BRILINTA® (ticagrelor) tablets | Heart Attack Treatmenthttp://site-overview.com/stats/brilinta.com
Read about BRILINTA® (ticagrelor) tablets, a prescription medication for heart attack treatment, or severe chest pain, also known as unstable angina.
- Website Address renewal date: 17/4/17
- Domain Address Reg. date: 05/4/21
- Website address in use until: 18/4/21
FASENRA™ (benralizumab) Subcutaneous Injection 30 mghttp://site-overview.com/stats/fasenra.com
FASENRA™ (benralizumab) is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in adults whose asthma is not controlled with their current asthma medicines.
- Website Address renewal date: 17/9/13
- Domain Address Reg. date: 16/8/1
- Website address in use until: 18/8/1
TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) | HCP Sitehttp://site-overview.com/stats/tudorzahcp.com
Healthcare professional information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.
- Website Address renewal date: 16/3/24
- Domain Address Reg. date: 12/5/10
- Website address in use until: 20/5/10
ONGLYZA® (saxagliptin) | Adult Type 2 Diabetes Medicationhttp://site-overview.com/stats/onglyza.com
Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to help reduce A1C levels.
- Website Address renewal date: 18/1/15
- Domain Address Reg. date: 06/1/19
- Website address in use until: 19/1/19
PI-Centralhttp://site-overview.com/stats/azpicentral.com
- Website Address renewal date: 16/1/29
- Domain Address Reg. date: 14/7/8
- Website address in use until: 17/7/8
SYNAGIS® (palivizumab) Parent & Caregiver Websitehttp://site-overview.com/stats/synagis.com
Parent and caregiver information for SYNAGIS, a therapy to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children at high risk for severe lung disease from RSV.
- Website Address renewal date: 17/9/4
- Domain Address Reg. date: 98/9/9
- Website address in use until: 18/9/8
Acid Reflux Medication | NEXIUM® (esomeprazole magnesium)http://site-overview.com/stats/purplepill.com
Discover NEXIUM, the Purple Pill, which offers 24-hour heartburn relief caused by acid reflux disease. Ask your doctor if NEXIUM may be right for you.
- Website Address renewal date: 16/10/25
- Domain Address Reg. date: 99/10/29
- Website address in use until: 17/10/29
FARXIGA® (dapagliflozin) | Type 2 Diabetes Medication for Adultshttp://site-overview.com/stats/farxiga.com
FARXIGA® (dapagliflozin) is an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.
- Website Address renewal date: 16/8/23
- Domain Address Reg. date: 13/8/27
- Website address in use until: 17/8/27
P&T Community |http://site-overview.com/stats/ptcommunity.com
- Google Analytics ID: 2492160-1
- Website Address renewal date: 15/7/22
- Domain Address Reg. date: 02/5/20
- Website address in use until: 17/5/20
FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) | Flu Vaccinehttp://site-overview.com/stats/flumistquadrivalent.com
Help protect against seasonal flu with FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) - the flu vaccine that starts working in the nose.
- Website Address renewal date: 16/12/2
- Domain Address Reg. date: 11/12/6
- Website address in use until: 17/12/6
LYNPARZA® (olaparib) | Ovarian Cancer Treatmenthttp://site-overview.com/stats/lynparza.com
LYNPARZA®(olaparib) is a type of targeted therapy for ovarian cancer called a PARP inhibitor. LYNPARZA may be used at different stages of ovarian cancer treatment.
- Website Address renewal date: 16/1/29
- Domain Address Reg. date: 14/2/10
- Website address in use until: 19/2/10
IRESSA® (gefitinib) Treatmenthttp://site-overview.com/stats/iressa-usa.com
IRESSA® (gefitinib) is a treatment for patients.
- Website Address renewal date: 17/6/4
- Domain Address Reg. date: 15/6/8
- Website address in use until: 18/6/8
PARP inhibitor for Advanced Ovarian Cancer | LYNPARZA® (olaparib)http://site-overview.com/stats/lynparzahcp.com
LYNPARZA® (olaparib) is the first and only PARP inhibitor approved in 2 distinct settings: maintenance for recurrent ovarian cancer and following 3 or more lines of prior chemotherapy.
- Website Address renewal date: 17/11/30
- Domain Address Reg. date: 14/12/4
- Website address in use until: 18/12/4
MOVANTIK® (naloxegol) | Opioid Induced Constipation Treatmenthttp://site-overview.com/stats/movantik.com
Official Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
- Website Address renewal date: 16/9/20
- Domain Address Reg. date: 13/9/25
- Website address in use until: 17/9/25
MOVANTIK® (naloxegol) | Mu-Opioid Receptor Antagonisthttp://site-overview.com/stats/movantikhcp.com
Official health care professional Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
- Website Address renewal date: 16/1/29
- Domain Address Reg. date: 14/2/14
- Website address in use until: 19/2/14
Bipolar Disorder Medication | SEROQUEL XR® (quetiapine fumarate)http://site-overview.com/stats/seroquelxr.com
Find information to better understand major depressive disorder (MDD), bipolar disorder, bipolar depression, and SEROQUEL XR® (quetiapine fumarate).
- Website Address renewal date: 17/3/25
- Domain Address Reg. date: 07/3/29
- Website address in use until: 18/3/29